Disagree
Home Pharmacom Labs Pharmacom Labs
PCT 102.5
PCT 102.5 - Pharmacom Labs

PCT 102.5 - Pharmacom Labs

Brand:
Category:
Substance:
Dosage:
102.5 mg/tab
Package:
60 tablets
Price:
$65.00 - $65.00
See options
Product Overview

This composite formulation unites four agents with distinct but complementary roles in hormonal modulation and performance restoration. Tamoxifen and Clomiphene, both SERMs developed in the 1960s–70s, stimulate endogenous testosterone through hypothalamic feedback. Proviron, a DHT-based androgen introduced in the 1930s by Schering, supports libido and SHBG displacement. Tadalafil, approved in 2003, enhances vascular response. Together, they form a multi-pathway compound aimed at post-cycle recovery and androgen support .

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about PCT 102.5 by Pharmacom Labs, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
Why is Clomiphene citrate often used in male fertility treatment?
Clomiphene citrate increases gonadotropin levels, which can stimulate sperm production and support fertility in men with low testosterone
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

When did Tadalafil citrate enter the pharmaceutical market?
Tadalafil citrate, developed by ICOS and Eli Lilly, was approved in 2003 as Cialis and became known for its long-acting erectile dysfunction relief.
References:

Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.

How does Tamoxifen citrate function as a selective estrogen receptor modulator (SERM)?
Tamoxifen citrate binds to estrogen receptors in certain tissues like the breast, acting as an antagonist to reduce estrogen-driven effects while sparing others.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.